APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sufentanil (API)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sufentanil (API) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025187 pages

Choose your research edition.

Industry ResearchSufentanil (API) Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Sufentanil (API) Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Sufentanil (API) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sufentanil (API) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sufentanil (API) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sufentanil (API) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sufentanil (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sufentanil (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sufentanil (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sufentanil (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sufentanil (API) include Janssen Pharmaceuticals, Kern Pharma, Hameln Rds, Cristalia and Cambrex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sufentanil (API) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sufentanil (API) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sufentanil (API) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sufentanil (API) market size, projected growth trends, production technologies, key applications, and end-use industries.

Sufentanil (API) Segment by Company

Janssen Pharmaceuticals

Kern Pharma

Hameln Rds

Cristalia

Cambrex

Sufentanil (API) Segment by Type

Purity 98%

Purity 99%

Sufentanil (API) Segment by Application

Injection

Capsule

Sufentanil (API) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sufentanil (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sufentanil (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sufentanil (API).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sufentanil (API) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sufentanil (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sufentanil (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sufentanil (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sufentanil (API) Industry Trends Table 2. Sufentanil (API) Industry Drivers Table 3. Sufentanil (API) Industry Opportunities and Challenges Table 4. Sufentanil (API) Industry Restraints Table 5. Global Sufentanil (API) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sufentanil (API) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sufentanil (API) Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Sufentanil (API) Sales Market Share by Manufacturers Table 9. Global Sufentanil (API) Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Sufentanil (API) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sufentanil (API) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sufentanil (API) Manufacturers, Product Type & Application Table 13. Global Sufentanil (API) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sufentanil (API) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Purity 98% Table 17. Major Manufacturers of Purity 99% Table 18. Global Sufentanil (API) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Sufentanil (API) Sales by Type (2021-2026) & (k units) Table 20. Global Sufentanil (API) Sales by Type (2027-2032) & (k units) Table 21. Global Sufentanil (API) Sales Market Share by Type (2021-2026) Table 22. Global Sufentanil (API) Sales Market Share by Type (2027-2032) Table 23. Global Sufentanil (API) Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Sufentanil (API) Revenue by Type (2021-2026) & (k units) Table 25. Global Sufentanil (API) Revenue by Type (2027-2032) & (k units) Table 26. Global Sufentanil (API) Revenue Market Share by Type (2021-2026) Table 27. Global Sufentanil (API) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Injection Table 29. Major Manufacturers of Capsule Table 30. Global Sufentanil (API) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Sufentanil (API) Sales by Application (2021-2026) & (k units) Table 32. Global Sufentanil (API) Sales by Application (2027-2032) & (k units) Table 33. Global Sufentanil (API) Sales Market Share by Application (2021-2026) Table 34. Global Sufentanil (API) Sales Market Share by Application (2027-2032) Table 35. Global Sufentanil (API) Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Sufentanil (API) Revenue by Application (2021-2026) & (k units) Table 37. Global Sufentanil (API) Revenue by Application (2027-2032) & (k units) Table 38. Global Sufentanil (API) Revenue Market Share by Application (2021-2026) Table 39. Global Sufentanil (API) Revenue Market Share by Application (2027-2032) Table 40. Global Sufentanil (API) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Sufentanil (API) Sales by Region (2021-2026) & (k units) Table 42. Global Sufentanil (API) Sales Market Share by Region (2021-2026) Table 43. Global Sufentanil (API) Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Sufentanil (API) Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Sufentanil (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Sufentanil (API) Sales by Country (2021-2026) & (k units) Table 47. North America Sufentanil (API) Sales by Country (2027-2032) & (k units) Table 48. Europe Sufentanil (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Sufentanil (API) Sales by Country (2021-2026) & (k units) Table 50. Europe Sufentanil (API) Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Sufentanil (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Sufentanil (API) Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Sufentanil (API) Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Sufentanil (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Sufentanil (API) Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Sufentanil (API) Sales by Country (2027-2032) & (k units) Table 57. Global Sufentanil (API) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Sufentanil (API) Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Sufentanil (API) Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Sufentanil (API) Revenue Market Share by Region (2021-2026) Table 61. Global Sufentanil (API) Revenue Market Share by Region (2027-2032) Table 62. Janssen Pharmaceuticals Company Information Table 63. Janssen Pharmaceuticals Business Overview Table 64. Janssen Pharmaceuticals Sufentanil (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Janssen Pharmaceuticals Sufentanil (API) Product Portfolio Table 66. Janssen Pharmaceuticals Recent Development Table 67. Kern Pharma Company Information Table 68. Kern Pharma Business Overview Table 69. Kern Pharma Sufentanil (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Kern Pharma Sufentanil (API) Product Portfolio Table 71. Kern Pharma Recent Development Table 72. Hameln Rds Company Information Table 73. Hameln Rds Business Overview Table 74. Hameln Rds Sufentanil (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Hameln Rds Sufentanil (API) Product Portfolio Table 76. Hameln Rds Recent Development Table 77. Cristalia Company Information Table 78. Cristalia Business Overview Table 79. Cristalia Sufentanil (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Cristalia Sufentanil (API) Product Portfolio Table 81. Cristalia Recent Development Table 82. Cambrex Company Information Table 83. Cambrex Business Overview Table 84. Cambrex Sufentanil (API) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Cambrex Sufentanil (API) Product Portfolio Table 86. Cambrex Recent Development Table 87. Key Raw Materials Table 88. Raw Materials Key Suppliers Table 89. Sufentanil (API) Distributors List Table 90. Sufentanil (API) Customers List Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Sufentanil (API) Product Image Figure 2. Global Sufentanil (API) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sufentanil (API) Market Size (2021-2032) & (US$ Million) Figure 4. Global Sufentanil (API) Sales (2021-2032) & (k units) Figure 5. Global Sufentanil (API) Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Sufentanil (API) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Purity 98% Image Figure 9. Purity 99% Image Figure 10. Global Sufentanil (API) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Sufentanil (API) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Sufentanil (API) Sales Market Share by Type (2021-2032) Figure 13. Global Sufentanil (API) Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Sufentanil (API) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Sufentanil (API) Revenue Market Share by Type (2021-2032) Figure 16. Injection Image Figure 17. Capsule Image Figure 18. Global Sufentanil (API) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Sufentanil (API) Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Sufentanil (API) Sales Market Share by Application (2021-2032) Figure 21. Global Sufentanil (API) Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Sufentanil (API) Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Sufentanil (API) Revenue Market Share by Application (2021-2032) Figure 24. North America Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Sufentanil (API) Sales Market Share by Country (2021-2032) Figure 26. U.S. Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Sufentanil (API) Sales Market Share by Country (2021-2032) Figure 31. Germany Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Sufentanil (API) Sales Market Share by Country (2021-2032) Figure 38. China Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Sufentanil (API) Sales Market Share by Country (2021-2032) Figure 46. Brazil Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Sufentanil (API) Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Sufentanil (API) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Sufentanil (API) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Sufentanil (API) Revenue (2021-2032) & (US$ Million) Figure 57. North America Sufentanil (API) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Sufentanil (API) Revenue (2021-2032) & (US$ Million) Figure 59. Europe Sufentanil (API) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Sufentanil (API) Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Sufentanil (API) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Sufentanil (API) Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Sufentanil (API) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Sufentanil (API) Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Sufentanil (API) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 98%
  • Purity 99%
Applications
  • Injection
  • Capsule
Companies covered
  • Janssen Pharmaceuticals
  • Kern Pharma
  • Hameln Rds
  • Cristalia
  • Cambrex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sufentanil (API) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sufentanil (API) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sufentanil (API) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sufentanil (API) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sufentanil (API) Market Dynamics
  1. 2.1 Sufentanil (API) Industry Trends
  2. 2.2 Sufentanil (API) Industry Drivers
  3. 2.3 Sufentanil (API) Industry Opportunities and Challenges
  4. 2.4 Sufentanil (API) Industry Restraints
3 Sufentanil (API) Market by Manufacturers
  1. 3.1 Global Sufentanil (API) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sufentanil (API) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sufentanil (API) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sufentanil (API) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sufentanil (API) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sufentanil (API) Manufacturers, Product Type & Application
  7. 3.7 Global Sufentanil (API) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sufentanil (API) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sufentanil (API) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sufentanil (API) Tier 1, Tier 2, and Tier 3
4 Sufentanil (API) Market by Type
  1. 4.1 Sufentanil (API) Type Introduction
  2. 4.1.1 Purity 98%
  3. 4.1.2 Purity 99%
  4. 4.2 Global Sufentanil (API) Sales by Type
  5. 4.2.1 Global Sufentanil (API) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sufentanil (API) Sales by Type (2021-2032)
  7. 4.2.3 Global Sufentanil (API) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Sufentanil (API) Revenue by Type
  9. 4.3.1 Global Sufentanil (API) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sufentanil (API) Revenue by Type (2021-2032)
  11. 4.3.3 Global Sufentanil (API) Revenue Market Share by Type (2021-2032)
5 Sufentanil (API) Market by Application
  1. 5.1 Sufentanil (API) Application Introduction
  2. 5.1.1 Injection
  3. 5.1.2 Capsule
  4. 5.2 Global Sufentanil (API) Sales by Application
  5. 5.2.1 Global Sufentanil (API) Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sufentanil (API) Sales by Application (2021-2032)
  7. 5.2.3 Global Sufentanil (API) Sales Market Share by Application (2021-2032)
  8. 5.3 Global Sufentanil (API) Revenue by Application
  9. 5.3.1 Global Sufentanil (API) Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sufentanil (API) Revenue by Application (2021-2032)
  11. 5.3.3 Global Sufentanil (API) Revenue Market Share by Application (2021-2032)
6 Global Sufentanil (API) Sales by Region
  1. 6.1 Global Sufentanil (API) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sufentanil (API) Sales by Region (2021-2032)
  3. 6.2.1 Global Sufentanil (API) Sales by Region (2021-2026)
  4. 6.2.2 Global Sufentanil (API) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sufentanil (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sufentanil (API) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sufentanil (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sufentanil (API) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sufentanil (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sufentanil (API) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sufentanil (API) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sufentanil (API) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sufentanil (API) Revenue by Region
  1. 7.1 Global Sufentanil (API) Revenue by Region
  2. 7.1.1 Global Sufentanil (API) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sufentanil (API) Revenue by Region (2021-2026)
  4. 7.1.3 Global Sufentanil (API) Revenue by Region (2027-2032)
  5. 7.1.4 Global Sufentanil (API) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sufentanil (API) Revenue (2021-2032)
  8. 7.2.2 North America Sufentanil (API) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sufentanil (API) Revenue (2021-2032)
  11. 7.3.2 Europe Sufentanil (API) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sufentanil (API) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sufentanil (API) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sufentanil (API) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sufentanil (API) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen Pharmaceuticals
  2. 8.1.1 Janssen Pharmaceuticals Company Information
  3. 8.1.2 Janssen Pharmaceuticals Business Overview
  4. 8.1.3 Janssen Pharmaceuticals Sufentanil (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Pharmaceuticals Sufentanil (API) Product Portfolio
  6. 8.1.5 Janssen Pharmaceuticals Recent Developments
  7. 8.2 Kern Pharma
  8. 8.2.1 Kern Pharma Company Information
  9. 8.2.2 Kern Pharma Business Overview
  10. 8.2.3 Kern Pharma Sufentanil (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Kern Pharma Sufentanil (API) Product Portfolio
  12. 8.2.5 Kern Pharma Recent Developments
  13. 8.3 Hameln Rds
  14. 8.3.1 Hameln Rds Company Information
  15. 8.3.2 Hameln Rds Business Overview
  16. 8.3.3 Hameln Rds Sufentanil (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hameln Rds Sufentanil (API) Product Portfolio
  18. 8.3.5 Hameln Rds Recent Developments
  19. 8.4 Cristalia
  20. 8.4.1 Cristalia Company Information
  21. 8.4.2 Cristalia Business Overview
  22. 8.4.3 Cristalia Sufentanil (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cristalia Sufentanil (API) Product Portfolio
  24. 8.4.5 Cristalia Recent Developments
  25. 8.5 Cambrex
  26. 8.5.1 Cambrex Company Information
  27. 8.5.2 Cambrex Business Overview
  28. 8.5.3 Cambrex Sufentanil (API) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cambrex Sufentanil (API) Product Portfolio
  30. 8.5.5 Cambrex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sufentanil (API) Value Chain Analysis
  2. 9.1.1 Sufentanil (API) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sufentanil (API) Production Mode & Process
  6. 9.2 Sufentanil (API) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sufentanil (API) Distributors
  9. 9.2.3 Sufentanil (API) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst